ByTrending Posts
Will Novo Nordisk Pull Ahead of Eli Lilly…
The U.S. Food and Drug Administration (FDA) has approved the first daily oral version of the obesity drug…
Is Tanya Alcorn Poised to Transform Pfizer’s Global…
Pfizer has appointed Tanya Alcorn as President, Global Hospital and Biosimilars, expanding her leadership responsibilities after serving more…
Is Pfizer Facing New Safety Scrutiny After Reporting…
Pfizer has disclosed that a patient enrolled in a clinical trial evaluating its investigational hemophilia treatment Hympavzi died…
How Is Pfizer Expanding Its Oncology Pipeline Through…
Cambridge, Massachusetts Pfizer is strengthening its oncology research pipeline through a new program launched under its strategic collaboration…
Will AI-Powered Prior Authorization Change How Medicare Care…
December 2025 — Medicare is preparing to introduce artificial intelligence–driven prior authorization reviews for certain medical services beginning…
Did 2025 Expose the Breaking Point of America’s…
New reflections from healthcare leaders highlight how events in 2025 revealed deep structural weaknesses in the U.S. health…
How Is Senhwa Biosciences Using AI and Strategic…
TAIPEI and SAN DIEGO — Senhwa Biosciences, Inc., a clinical-stage biopharmaceutical company focused on first-in-class therapies for oncology,…
Will the European Commission’s New Health Policy Package…
The European Commission has unveiled a new health policy package to strengthen innovation, competitiveness, and resilience across the…
U.S. FDA Approves JASCAYD® for Progressive Pulmonary Fibrosis…
Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has approved JASCAYD® (nerandomilast) tablets for the…
Trending Posts
Latest Stories
Can TrumpRx and Pfizer’s Discount Deal Reshape Prescription Drug Pricing in the U.S.?
Washington, D.C. The U.S. administration has announced the launch of TrumpRx, a federally operated digital…
Is McRae Tech Setting a New Standard for Scalable AI in Healthcare with Its Orchestral Platform?
McRae Tech has introduced Orchestral, a health-focused AI orchestrator data platform designed to support large-scale,…
Is Sanofi Strengthening Its Adult Vaccine Strategy with a $2.2 Billion Dynavax Deal?
Paris, France Sanofi has taken a major step to strengthen its adult vaccines portfolio by…
Has Sanofi’s Dupixent Been Approved for Pediatric Asthma in Japan?
Tokyo, Japan – December 23, 2025 Sanofi and Regeneron have received regulatory approval in Japan…
Gallery
